Microparticles and exosomes in gynecologic neoplasias

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 8, 2010, Pages 925-929

  Nieuwland, Rienk ^a   Van Der Post, Joris A M ^a   Lok Gemma, Christianne A R ^a   Kenter, G ^a   Sturk, Augueste ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

cancer; exosome; gynecologic malignancy; Microparticle

Indexed keywords

CISPLATIN; PROTEINASE;

BLOOD CLOTTING; BREAST CANCER; CANCER GROWTH; DRUG RESISTANCE; ENZYME ACTIVITY; EXOSOME; EXTRACELLULAR MATRIX; GYNECOLOGIC CANCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEMBRANE MICROPARTICLE; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

CELL-DERIVED MICROPARTICLES; DISEASE PROGRESSION; EXOSOMES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 78149347674     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1267046     Document Type: Review

References (31)

1. Toth B, Lok C A., Bing A et al. Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immunol 2007 58 (5) 389-402
2. Dvorak H F., Quay S C., Orenstein N S. et al. Tumor shedding and coagulation. Science 1981 212 (4497) 923-924
3. Dvorak H F., Van DeWater L, Bitzer A M. et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983 43 (9) 4434-4442
4. Kakkar A K., DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson R C. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995 346 (8981) 1004-1005
5. Goyal D, Choudhury A, Lip G Y. Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies. Curr Opin Obstet Gynecol 2005 17 (1) 13-20
6. Satoh T, Matsumoto K, Uno K et al. Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. Br J Cancer 2008 99 (7) 1034-1039
7. Uno K, Homma S, Satoh T et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 2007 96 (2) 290-295
8. Tesselaar M E., Romijn F P., Van Der Linden I K., Prins F A., Bertina R M., Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007 5 (3) 520-527
9. Yokota N, Koizume S, Miyagi E et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer 2009 101 (12) 2023-2029
10. Keller S, Knig A K., Marm F et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett 2009 278 (1) 73-81
11. Liu C, Yu S, Zinn K et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006 176 (3) 1375-1385
12. Dolo V, Pizzurro P, Ginestra A, Vittorelli M L. Inhibitory effects of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-beta antibodies. J Submicrosc Cytol Pathol 1995 27 (4) 535-541
13. Abrahams V M., Straszewski S L., Kamsteeg M et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res 2003 63 (17) 5573-5581
14. Frngsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 2005 11 (1) 35-41
15. Taylor D D., Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 2006 176 (3) 1534-1542
16. Martin L P., Schilder R J. Management of recurrent ovarian carcinoma: current status and future directions. Semin Oncol 2009 36 (2) 112-125
17. Hamilton K K., Hattori R, Esmon C T., Sims P J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990 265 (7) 3809-3814
18. Safaei R, Larson B J., Cheng T C. et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 2005 4 (10) 1595-1604
19. Dolo V, D'Ascenzo S, Violini S et al. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 1999 17 (2) 131-140
20. Graves L E., Ariztia E V., Navari J R., Matzel H J., Stack M S., Fishman D A. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004 64 (19) 7045-7049
21. Runz S, Keller S, Rupp C et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol 2007 107 (3) 563-571
22. Dolo V, Ginestra A, Ghersi G, Nagase H, Vittorelli M L. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submicrosc Cytol Pathol 1994 26 (2) 173-180
23. Ginestra A, Miceli D, Dolo V, Romano F M., Vittorelli M L. Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 1999 19 (4C) 3439-3445
24. Stoeck A, Keller S, Riedle S et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 2006 393 (Pt 3) 609-618
25. Gutwein P, Stoeck A, Riedle S et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res 2005 11 (7) 2492-2501
26. Taylor D D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008 110 (1) 13-21
27. Taylor D D., Gercel-Taylor C, Parker L P. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 2009 115 (1) 112-120
28. Li J, Sherman-Baust C A., Tsai-Turton M, Bristow R E., Roden R B., Morin P J. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 2009 9 244
29. Ochieng J, Pratap S, Khatua A K., Sakwe A M. Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes. Exp Cell Res 2009 315 (11) 1875-1888
30. Al-Nedawi K, Meehan B, Micallef J et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008 10 (5) 619-624
31. Skog J, Wrdinger T, van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008 10 (12) 1470-1476